A study of evaluating the effect of oral intake of BARLEYmax on human skin condition. A randomized, double-blind, placebo-controlled trial.
Not Applicable
- Conditions
- one
- Registration Number
- JPRN-UMIN000033937
- Lead Sponsor
- DeNA Life Science Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Individuals who are participating in other clinical trials. (2)Individuals who may develop allergic symptoms due to wheat.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Questionnaires regarding to skin condition
- Secondary Outcome Measures
Name Time Method Questionnaires regarding to feces and systemic health Blood test(IgE, TARC, eosinophil) Gut microbiota Free description